Targeting Polymerase beta in BER pathway

Project: Research project

Project Details

Description

Project highlights: the primary qHTS screen was run, and follow-up cherry picks were tested in panel assays of different TLS polymerases and DNA modifying enzymes for final compounds selection. Further compounds validation are ongoing in cell and gel-based assays. During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
StatusFinished
Effective start/end date9/30/066/30/16

Funding

  • National Institutes of Health: $150,797.00
  • National Institutes of Health: $150,797.00
  • National Institutes of Health: $154,771.00
  • National Institutes of Health: $137,802.00

ASJC

  • Medicine(all)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.